Predictors of one-year mortality in hemodialysis patients with end-stage renal disease at a Kenyan county hospital

doi:10.5527/wjn.v15.i2.118111

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

(16)

(18)

(0)

(19)

(288)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Nephrol. Jun 25, 2026; 15(2): 118111
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.118111

Table 1 Baseline characteristics of 79 hemodialysis patients, n (%)/median (interquartile range)

Characteristic	Overall (n = 79)	Survivors (n = 52)	Non-survivors (n = 27)	P value
Demographics
Age (years)	62.0 (48.0-74.0)	58.0 (45.0-68.0)	73.0 (65.0-76.0)	< 0.001
Male sex	52 (65.8)	35 (67.3)	17 (63.0)	0.693
Primary ESRD cause				0.145
Hypertension	38 (48.1)	22 (42.3)	16 (59.3)
Diabetes mellitus	32 (40.5)	20 (38.5)	12 (44.4)
Chronic GN	16 (20.3)	12 (23.1)	4 (14.8)
Comorbidities
Hypertension	68 (86.1)	43 (82.7)	25 (92.6)	0.221
Diabetes mellitus	32 (40.5)	20 (38.5)	12 (44.4)	0.607
HIV	14 (17.7)	8 (15.4)	6 (22.2)	0.430
BPH	8 (10.1)	6 (11.5)	2 (7.4)	0.571
SLE	3 (3.8)	2 (3.8)	1 (3.7)	0.984
Bladder cancer	2 (2.5)	1 (1.9)	1(3.7)	0.629
Baseline laboratory
Hemoglobin (g/dL)	8.2 (7.1-9.3)	8.6 (7.5-9.5)	7.1 (6.3-8.4)	0.008
eGFR (mL/minute/1.73 m²)	7.8 (5.4-10.2)	8.1 (6.0-10.8)	6.2 (4.8-8.1)	0.023
Treatment parameters
Vascular access				0.018
Central venous catheter	71 (89.9)	44 (84.6)	27 (100.0)
Arteriovenous fistula	8 (10.1)	8 (15.4)	0 (0.00)

Using the Mann-Whitney U test. Categorical variables are presented as counts (percentages) and compared using Fisher’s exact test. BPH: Benign prostatic hyperplasia; eGFR: Estimated glomerular filtration rate; ESRD: End-stage renal disease; GN: Glomerulonephritis; HIV: Human immunodeficiency virus; IQR: Interquartile range; SLE: Systemic lupus erythematosus.

Full Size Table

Citation: Omullo FP, Kitheghe TK, Mark MM, Ng’ang’a AK, Parsimei MW, Kanyi WC, Emma OA, Sheikh IA, Gitumu JM, Gakuya AM, Gitonga GK, Ndung’u JA, Nyaro EM. Predictors of one-year mortality in hemodialysis patients with end-stage renal disease at a Kenyan county hospital. World J Nephrol 2026; 15(2): 118111
URL: https://www.wjgnet.com/2220-6124/full/v15/i2/118111.htm
DOI: https://dx.doi.org/10.5527/wjn.v15.i2.118111

Omullo FP, Kitheghe TK, Mark MM, Ng’ang’a AK, Parsimei MW, Kanyi WC, Emma OA, Sheikh IA, Gitumu JM, Gakuya AM, Gitonga GK, Ndung’u JA, Nyaro EM. Predictors of one-year mortality in hemodialysis patients with end-stage renal disease at a Kenyan county hospital. World J Nephrol 2026; 15(2): 118111 [PMID: 42395657 DOI: 10.5527/wjn.v15.i2.118111]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.